Clinic
Slidell Memorial Hospital
Slidell Memorial Hospital was paid $3.27M by Medicaid between Jan 2018 and Jun 2024, across 76 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoSLIDELL MEMORIAL HOSPITAL
SLIDELL, LA 70458
SLIDELL, LA 70458
33aNPI1801020433assigned 05/11/2009
33bProvider typeClinic/Center
28Total paid$3.27M
24GClaims181,902
24DCodes billed76
24AFirst – last monthJan 2018 – Jun 2024
Compared with peers
Next to other Clinic/Center providers in Louisiana
Rank by total paid#10 of 112
Median peer was paid$138K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,370 | $294K | |
| 2019 | 12,265 | $383K | |
| 2020 | 14,985 | $508K | |
| 2021 | 19,843 | $704K | |
| 2022 | 60,521 | $709K | |
| 2023 | 60,798 | $633K | |
| 2024incomplete | 4,120 | $41K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 28,871 | 26,158 | $1.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 29,131 | 26,204 | $988K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.1% | 3,185 | 1,374 | $135K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 2,007 | 1,793 | $116K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 1,283 | 1,234 | $88K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.6% | 6,799 | 6,047 | $86K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.6% | 2,945 | 1,174 | $86K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 1,340 | 1,278 | $68K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.9% | 657 | 178 | $64K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 718 | 684 | $55K |
| 20610 | 1.5% | 1,341 | 1,188 | $48K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 3,074 | 2,821 | $39K |
64 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 292 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,896 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 328 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 385 | $17K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,021 | $17K |
| 73562 | <1% | 973 | $16K | |
| 99223 | Prolong inpt eval add15 m | <1% | 258 | $15K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 498 | $15K |
| 72100 | <1% | 733 | $12K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 76 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,028 | $10K |
| 94729 | <1% | 782 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 268 | $7K |
| 94727 | <1% | 769 | $7K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 98 | $7K |
| 90682 | <1% | 144 | $7K | |
| 73030 | <1% | 348 | $5K | |
| 90474 | <1% | 628 | $5K | |
| 87807 | <1% | 276 | $3K | |
| 94060 | <1% | 217 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 32 | $2K |
| 90686 | <1% | 1,172 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 94010 | <1% | 165 | $1K | |
| 90715 | <1% | 46 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,052 | $933.66 |
| 72170 | <1% | 73 | $917.47 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $730.26 |
| 73130 | <1% | 42 | $725.21 | |
| 72040 | <1% | 45 | $632.63 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 125 | $430.11 |
| 81003 | <1% | 271 | $386.39 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 937 | $343.78 |
| 95115 | <1% | 48 | $278.39 | |
| 73630 | <1% | 36 | $222.41 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 15 | $166.68 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 16 | $77.30 |
| 3044F | <1% | 1,484 | $40.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 55 | $28.41 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 14 | $24.21 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 45 | $7.28 |
| 90633 | <1% | 297 | $1.40 | |
| 3074F | <1% | 8,216 | $1.04 | |
| 90670 | <1% | 1,211 | $0.86 | |
| 3078F | <1% | 6,550 | $0.86 | |
| 90619 | <1% | 16 | $0.45 | |
| 3079F | <1% | 2,872 | $0.36 | |
| 3075F | <1% | 940 | $0.18 | |
| 90697 | <1% | 33 | $0.08 | |
| 3008F | 0% | 18,216 | $0.00 | |
| 4010F | 0% | 1,874 | $0.00 | |
| 90680 | 0% | 602 | $0.00 | |
| 90698 | 0% | 115 | $0.00 | |
| 3080F | 0% | 24 | $0.00 | |
| 90723 | 0% | 25 | $0.00 | |
| 3066F | 0% | 84 | $0.00 | |
| 90744 | 0% | 25 | $0.00 | |
| 1159F | 0% | 23,133 | $0.00 | |
| 90648 | 0% | 136 | $0.00 | |
| 1160F | 0% | 19,249 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| 90710 | 0% | 34 | $0.00 | |
| 3077F | 0% | 138 | $0.00 | |
| 90685 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBADINGER, SANDRA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Slidell Memorial Hospital | Slidell, LA | $11.85M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.